Preserving Patient Access to Home Infusion Act
Key claim: HR2172 would expand Medicare-covered home infusion therapy to include drugs administered without a pump and allow nurses and physician assistants to establish and review plans of care without requiring a practitioner to be physically present.
Abstract
(HR2172 · 119th Congress) Preserving Patient Access to Home Infusion Act This bill specifically includes pharmacy services and home infusion drugs that are administered without a pump as part of covered home infusion therapy under Medicare. The bill also allows nurses and physician assistants to establish and review the plan of care for home infusion therapy, and it specifies that payment may be made regardless of whether a practitioner is physically present in the home at the time the drug is administered. Latest action (2025-03-18): Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Why this matters
Medicare’s home infusion therapy benefit currently covers only pump-administered drugs and requires physician presence for plan-of-care decisions, limiting which patients can receive infusions at home and under whose supervision. HR2172 would broaden both the drug categories eligible for home administration and the clinicians authorized to direct care, potentially shifting more infusion services out of hospital and infusion-center settings for Medicare beneficiaries.